These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22393083)

  • 41. [Carcinoma in situ. Prognostic factors].
    Trojani M
    Arch Anat Cytol Pathol; 1994; 42(5):234-50. PubMed ID: 7872815
    [No Abstract]   [Full Text] [Related]  

  • 42. Primary breast cancer phenotypes associated with propensity for central nervous system metastases.
    Tham YL; Sexton K; Kramer R; Hilsenbeck S; Elledge R
    Cancer; 2006 Aug; 107(4):696-704. PubMed ID: 16826579
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinicopathologic correlation of cancer stem cell markers CD44, CD24, VEGF and HIF-1α in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
    Wang Z; Shi Q; Wang Z; Gu Y; Shen Y; Sun M; Deng M; Zhang H; Fang J; Zhang S; Xie F
    Pathol Res Pract; 2011 Aug; 207(8):505-13. PubMed ID: 21802218
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Different distribution of breast cancer subtypes in breast ductal carcinoma in situ (DCIS), DCIS with microinvasion, and DCIS with invasion component.
    Yu KD; Wu LM; Liu GY; Wu J; Di GH; Shen ZZ; Shao ZM
    Ann Surg Oncol; 2011 May; 18(5):1342-8. PubMed ID: 21042943
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in situ ductal carcinoma (IDC + DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade.
    Papantoniou V; Sotiropoulou E; Valsamaki P; Tsaroucha A; Sotiropoulou M; Ptohis N; Stipsanelli A; Dimitrakakis K; Marinopoulos S; Tsiouris S; Antsaklis A
    Breast Cancer; 2011 Oct; 18(4):286-91. PubMed ID: 20143189
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Over expression of RhoA is associated with progression in invasive breast duct carcinoma.
    Ma L; Liu YP; Geng CZ; Wang XL; Wang YJ; Zhang XH
    Breast J; 2010; 16(1):105-7. PubMed ID: 19912238
    [No Abstract]   [Full Text] [Related]  

  • 47. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
    Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Toker-cell pathology as a unifying concept.
    Fernandez-Flores A
    Histopathology; 2008 Jun; 52(7):889-91; author reply 891-2. PubMed ID: 18462365
    [No Abstract]   [Full Text] [Related]  

  • 49. Clinicopathologic and prognostic evaluation of invasive breast carcinoma molecular subtypes and GATA3 expression.
    Demir H; Turna H; Can G; Ilvan S
    J BUON; 2010; 15(4):774-82. PubMed ID: 21229645
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinical characteristics and prognosis of breast cancer patients with vascular invasion].
    Zhao WH; Xu BH; Zhang P; Li Q; Zhao LM; Sun Y
    Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):137-40. PubMed ID: 17645853
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alpha- and beta-adrenergic receptor (AR) protein expression is associated with poor clinical outcome in breast cancer: an immunohistochemical study.
    Powe DG; Voss MJ; Habashy HO; Zänker KS; Green AR; Ellis IO; Entschladen F
    Breast Cancer Res Treat; 2011 Nov; 130(2):457-63. PubMed ID: 21298476
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ductal type signet ring cell carcinoma of breast with growth pattern of pure mucinous carcinoma.
    Leung KM; Yeoh GP; Chan JK; Cheung PS; Chan KW
    Pathology; 2011 Apr; 43(3):282-4. PubMed ID: 21436644
    [No Abstract]   [Full Text] [Related]  

  • 53. Ductal carcinoma in situ of the breast.
    Silverstein MJ
    Annu Rev Med; 2000; 51():17-32. PubMed ID: 10774450
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Concurrent primary angiosarcoma and invasive ductal carcinoma in the same breast.
    Ni Y; Xie X; Bu H; Zhang Z; Wei B; Yin L; Chen M; Chen H; Zhang H
    J Clin Pathol; 2013 Mar; 66(3):263-4. PubMed ID: 23172554
    [No Abstract]   [Full Text] [Related]  

  • 55. HER2-positive breast cancer metastatic to intracranial meningioma: a case report.
    McCormack M; Rosa CS; Murphy M; Fox SB
    J Clin Pathol; 2013 Jul; 66(7):633-4. PubMed ID: 23436926
    [No Abstract]   [Full Text] [Related]  

  • 56. [Recent advances in studies on in-situ and invasive ductal carcinoma].
    Zhang RJ; Niu Y; Gao YX
    Zhonghua Bing Li Xue Za Zhi; 2009 Jan; 38(1):63-5. PubMed ID: 19489232
    [No Abstract]   [Full Text] [Related]  

  • 57. Letter to the editor: Breast cancer in young women in Africa: are there genetic and clinical differences with European ancestry patients?
    Baltogiannis G; Roukos DH
    World J Surg; 2010 Aug; 34(8):1982-3. PubMed ID: 20130864
    [No Abstract]   [Full Text] [Related]  

  • 58. Immunohistochemical profile of the estrogen and progesterone receptors in mammary benign lesions.
    Moise M; Răducan S; Boscu A; Jianu A; Niculescu M; Selaru M; Motoc A
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):875-82. PubMed ID: 23272545
    [TBL] [Abstract][Full Text] [Related]  

  • 59. National treatment trends for ductal carcinoma in situ of the breast. Arch Surg 1997 Jun;132:660-665.
    Morrow M
    J Womens Health; 1998 Mar; 7(2):267-8. PubMed ID: 9555693
    [No Abstract]   [Full Text] [Related]  

  • 60. Ductal carcinoma in situ of the breast: progress and controversy.
    Swallow CJ; Van Zee KJ; Sacchini V; Borgen PI
    Curr Probl Surg; 1996 Jul; 33(7):553-600. PubMed ID: 8765465
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.